Nolato Ab Class B · OMXSTO:NOLA_B
Nolato Ab Class B — Q2 2026 Earnings Presentation
12 slides from Nolato Ab Class B's earnings presentation, Jul 17, 2026
Slide 1: Second quarter
Medical Solutions Second quarter Engineered Solutions CEO Christer Wahlquist CFO Per-Ola Holmström July 17, 2026 1
Slide 2: Q2 Summary – Nolato Group
Q2 Summary – Nolato Group A global solutions provider established on three continents ● Sales increased to SEK 2,454 million (2,395) - Organic growth of 4% adjusted for currency SEKm * Medical Solutions +4% 12000 * Engineered Solutions +3% 11000 10000 ● Operating profit (EBITA) was SEK 247 million (
Slide 3: One Group – two Business Areas
One Group – two Business Areas Nolato Medical Solutions Engineered Solutions Our offering as a strategic partner for Advanced components, subsystems and Design, development, industrialization and selected global customers comprises complete products are developed and manufacture of advanced componen
Slide 4: Medical Solutions – sustainable growth and global expansion
Medical Solutions – sustainable growth and global expansion SEKm 5500 5000 4500 4000 3500 1,388 162 3000 2500 2000 SALES, SEKm EBITA-RESULT, SEKm Q2 Q2 1500 1000 56 11.7 500 0 SHARE OF THE GROUP, % EBITA-MARGIN, % 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 R12M Q2 Q2 4
Slide 5: Medical Solutions – focused product areas
Medical Solutions – focused product areas Pharma Diagnostics Medical Devices Drug delivery In vitro diagnostics (IVD) Endoscopy & general surgery Cardiology Continence care Pharma packaging Other 5
Slide 6: Medical Solutions – Q2
Medical Solutions – Q2 ● Sales totaled SEK 1,388 million (1,354) - An increase of 4% adjusted for currency - The in vitro diagnostics (IVD) market segment increased with a higher proportion of new products Q2 Acc. 6 months - Drug Delivery continued its upbeat performance - Other market areas had sta
Slide 7: Engineered Solutions – advanced technology and high-productivity manufacturing
Engineered Solutions – advanced technology and high-productivity manufacturing SEKm 8000 7500 7000 6500 6000 5500 5000 4500 1,070 110 4000 3500 3000 SALES, SEKm EBITA-RESULT, SEKm 2500 Q2 Q2 2000 1500 44 10.3 1000 500 0 SHARE OF THE GROUP, % EBITA-MARGIN, % 07 08 09 10 11 12 13 14 15 16 17 18 19 20
Slide 8: Engineered Solutions – focused product areas
Engineered Solutions – focused product areas Materials Consumer electronics Automotive Other Hygiene 8
Slide 9: Engineered Solutions – Q2
Engineered Solutions – Q2 ● Sales totaled SEK 1,070 million (1,044) - Increase of 3% adjusted for currency Q2 Acc. 6 months - Strong growth for Materials, which increased by a full 19% organically SEKm 2026 2025 2026 2025 - Sustained growth in the Consumer Electronics market area, with an increase i
Slide 10: Group financial highlights
Group financial highlights Q2 Q2 Acc. 6 months Full yr. SEKm 2026 2025 2026 2025 R12M 2025 Net sales 2,454 2,395 4,811 4,848 9,425 9,462 Operating profit (EBITA) 247 277 507 548 1,024 1,065 EBITA margin (%) 10.1 11.6 10.5 11.3 10.9 11.3 Profit after financial income and expense 220 264 452 516 919 9
Slide 11: Current situation
Current situation Medical Solutions Engineered Solutions • Continued growth strategy – high market activity • Advanced market positions, not least in Consumer • Innovation and sustainability electronics • Broad customer base with longstanding, close • Established position in new product areas custom
Slide 12: Thank you!
Thank you! This presentation may contain forward-looking statements. When used in this presentation, words such as “anticipate”, “believe”, “estimate”, “expect”, “plan” and “project” are intended to identify forward-looking statements. Such statements could encompass risks and uncertainties pertaini